Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating an ocular condition by administering multispecific antibodies that activates TIE2 and binds a receptor tyrosine kinase agonist

Method of treating an ocular condition by administering multispecific antibodies that activates TIE2 and binds a receptor tyrosine kinase agonist

US Patent 12398204 · Granted Aug 26, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating intraocular pressure with activators of Tie-22024
Compositions, formulations and methods for treating ocular diseases2024
Method of treating an ocular condition by administering a humanized monoclonal a2024
Tie-2 activators targeting the Schlemm's canal2024
Methods for treating vascular leak syndrome and cancer2024
Method of treating ocular conditions by administering an antibody that activates2024
Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses2023
Methods of treating intraocular pressure with activators of Tie-22023
Formulations of Tie-2 activators and methods of use thereof2022
Tie-2 activators targeting the Schlemm's canal2022
Humanized monoclonal antibodies that target VE-PTP (HPTP-beta)2021
Humanized monoclonal antibodies that target VE-PTP (HPTP-β)2021